1、 1 Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement,make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in rel
2、iance upon the whole or any part of the contents of this announcement.China Health Group Limited中國衛生集團有限公司(Carrying on business in Hong Kong as CHG HS Limited)(Incorporated in Bermuda with limited liability)(Stock Code:673)CLARIFICATION ANNOUNCEMENT ON ANNUAL RESULTSANNOUNCEMENT FOR THE YEAR ENDED 3
3、1 MARCH 2026Reference is made to the annual results announcement of China Health Group Limited(the“Company”)for the year ended 31 March 2026(the“Annual Results Announcement”).Capitalised terms used in this announcement have the same meanings as those defined in the Annual Results Announcement unless
4、 defined otherwise herein.The Company noted that there are inadvertent errors in certain figures,wordings and referencing in English and Chinese versions of the Annual Results Announcement.Therefore,the Company wishes to clarify certain information in the Annual Results Announcement as follows(with
5、amendments underlined and in bold):2 For both English and Chinese versions of the Annual Results Announcement:1.Consolidated Statement of Profit or Loss(pages 1-2 of the Annual Results Announcement)CONSOLIDATED STATEMENT OF PROFIT OR LOSSFor the year ended 31 March 2026For the year ended 31 March202
6、62025NotesHK$000HK$000Revenue441,09238,943Cost of sales(33,964)(29,708)Gross profit7,1289,235Other income579116,689Other loss,net5(4,026)(6,575)Net impairment loss of financial assets(11,252)(17,642)Selling and distribution expenses(2,930)(6,138)Administrative expenses(38,376)(62,695)OPERATING LOSS(